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n INTRODUCTION
Metabolic syndrome, which consists of a clus-ter of metabolically related factors, includ-
ing central obesity, raised blood pressure, an ele-
vated level of serum triglycerides, decreased level 
of HDL-cholesterol, and impaired glucose toler-
ance, was first proposed by Reaven in 1988 and 
has been well recognized as a powerful predictor 
of diabetes, and cardiovascular disease morbidity 
and mortality [1-4]. 
Increase in abdominal adipose tissue is the most 
important determinant of metabolic syndrome in 
developed and developing countries [5, 6]. More-
over, the adipose tissue is now recognized as an 
immune organ that secretes numerous immuno-
modulatory factors and seems to be a significant 
source of inflammatory signals known to cause 
insulin resistance and alterations in immunologic 
functions [7].
Most people with metabolic syndrome have high-
er body mass index (BMI) and are overweighed or 
obese. Some metabolically obese normal-weight 
(MONW) individuals despite of having a nor-
mal-weight BMI, demonstrate metabolic distur-
bances. On the other hand, there are some met-
abolically healthy obese (MHO) individuals with 
BMI exceeding 30 kg/m2, are relatively insulin 
sensitive and do not have metabolic syndrome. 
Therefore these terms should not be considered 
equivalent [8].
The outbreak of swine-origin influenza A (H1N1) 
virus that has been called later influenza A 
(H1N1) pdm09, began in April 2009 and became 
a pandemic in the subsequent months. That strain 
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A swine-origin influenza A (H1N1) emerged as a pan-
demic in 2009. We investigated the association be-
tween the overweight, metabolic syndrome and the 
severity of disease in the confirmed cases in Qazvin 
province, Iran. The study sample included all patients 
over 12 years old with confirmed influenza A (H1N1) 
in the province of Qazvin, Iran, in the 2009 pandem-
ic, excluding pregnant women. To define overweight, 
sex and age-specific body mass index (BMI) cutoffs 
recommended by the International Obesity Task Force 
were used. Metabolic syndrome was defined by ATP 
III criteria. Multiple logistic regression analysis was 
performed to identify statistically independent pre-
dictors of hypoxaemia. Out of 55 confirmed cases, 28 
SUmmARY
(50.9%) were overweight and 24 (45.3%) were identi-
fied as having metabolic syndrome by ATP III criteria. 
Twenty four patients had hypoxaemia (arterial oxygen 
saturation below 90%) during the course of the disease. 
In multivariate logistic regression analysis, pulmonary 
co-morbidity (OR=9.54; 95% CI, 1.36 to 66.88; p=0.023) 
and the metabolic syndrome (OR=18.66; 95% CI, 1.60 
to 217.47; p=0.019) were revealed to be independent 
risk factors for hypoxaemia in influenza A (H1N1) 
pdm09. The results of the present study reveal the role 
of the metabolic syndrome on the severity of influenza 
A (H1N1) pdm09 infection.
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of H1N1 influenza seems to be highly infectious 
with low mortality. Higher incidence, in the 
younger age groups, was one of the most import-
ant characteristics of this pandemic and in some 
investigations up to 60% of patients were under 
18 years old. 
The first confirmed case of the disease in Qazvin, 
Iran, was discovered in July 2009 and subsequent-
ly 76 additional confirmed cases of infection were 
detected throughout the entire province [9]. 
Considering the reports on more severe course of 
influenza A (H1N1) pdm09 infection in obese per-
sons, inconsistent results in later reports regarding 
the role of obesity in the prognosis of swine-origin 
influenza A (H1N1), and observing the more severe 
hypoxaemia in individuals with central obesity in 
our hospitalized patients; the present study was 
designed to investigate the correlation between 
both overweight and metabolic syndrome and hy-
poxaemia in the confirmed cases of novel H1N1 
influenza in the province of Qazvin, Iran [10-12]. 
n PATIENTS AND mETHODS
Study design
This was a cross-sectional study performed in 
the province of Qazvin (Iran) during July to De-
cember 2009. Samples were taken from all pa-
tients with clinical symptoms of severe influenza 
throughout the province of Qazvin. The sampling 
method and the equipment, primers and probes 
used for viral RNA extraction and amplification 
were explained in detail previously [9]. 
Among the positive cases, those under 12 years, 
pregnant women or women in the first month 
after delivery were excluded and the remaining 
(55 patients) entered the study. Data concerning 
demographics, occupation and ethnicity were 
recorded. During a physical examination, blood 
pressure, height and weight were measured us-
ing standardized protocols and calibrated equip-
ment. Body mass index (BMI) was calculated as 
weight in kilograms divided by the square of 
height in meters and was rounded to the near-
est tenth. Fasting blood sugar, triglycerides, and 
HDL cholesterol levels were checked and when 
unavailable, the data were extracted from the pa-
tients’ medical records. Pulse oxymetry was per-
formed at the first visit for all patients. Patients 
with tachypnea (regardless of the result of pulse 
oxymetry) were admitted to province hospitals. 
Among the hospitalized patients, the lowest per-
centage of arterial oxygen saturation during the 
hospitalization period was recorded.
Definitions
Hypoxaemia was defined as arterial oxygen sat-
uration less than 90% in pulse oxymetry. Pulmo-
nary co-morbidity was defined as having asthma 
or chronic obstructive pulmonary disease or other 
chronic pulmonary disorders.
Overweight was defined as BMI>25 and obesity 
as BMI>30 in adults. In children and adolescents, 
standard age and sex specific cutoffs recommend-
ed by International Obesity Task Force for over-
weight and obesity were used [13]. 
There are various criteria for definition of meta-
bolic syndrome, but the clinical-friendly nature 
of the National Cholesterol Education Program 
(NCEP)-Adult Treatment Panel (ATP)-III criteria 
has caused the widespread use of these criteria in 
adults and adolescents. 
Diagnosis of the metabolic syndrome was accom-
plished considering the presence of three or more 
measures of the NCEP Adult Treatment Panel III 
criteria (waist circumference of greater than 88cm 
in women and 102 cm in men, arterial blood pres-
sure higher than 130/85 mmHg, serum triglycer-
ide level >150 mg/dL, serum HDL concentration 
<50 mg/dL for women and <40 mg/dL for men, 
and fast blood sugar over 110 mg/dL [14].
 In younger patients (12-20 years old) the age-spe-
cific cutoff points of metabolic syndrome criteria 
in adolescents that were linked to the NCEP adult 
criteria were considered [15].
Statistical methods
Data were entered in Epi Info 3.5.1 software. 
Univariate analysis of quantitative data was per-
formed using independent t-test and those of 
qualitative variables by chi-square and Fisher ex-
act test while the multivariable analysis was ac-
complished through multivariate logistic regres-
sion. A P-value of less than 0.05 was considered to 
indicate statistical significance.
n RESULTS
In the period between July and December 2009, 
76 confirmed cases of new influenza A (H1N1) 
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pdm09 infection were discovered in the province 
of Qazvin. The median age of patients was 23 
years and the mean age 25.67±16.9. After exclud-
ing those under 12 years and pregnant women, 
55 patients entered the study. Demographic, clin-
ical characteristics and laboratory test results are 
shown in Tables 1 and 2, respectively.
Twenty six (47.3%) patients out of the total were 
found to have the ATP III criteria associated with 
metabolic syndrome. Mean of BMI in patients 
having metabolic syndrome was 28.09±13.61 
while in the remaining patients it was 22.48±13.62. 
(P<0.001) All hospitalized patients (44 cases) were 
sufficiently ill and tachypneic to put under treat-
ment with oseltamivir and oxygen. Among these 
patients, 24 had at least one period of arterial 
oxygen saturation of less than 90% during the 
course of disease. Overall, 9 cases were admit-
ted to ICUs among those 8 patients needed in-
tubation and eventually 2 patients died. As seen 
in Table 3, the values obtained for BMI, weight, 
and waist circumference in hypoxaemic group 
were significantly higher than nonhypoxaemic 
patients. Also, it is evident that the factors such as 
overweight and obesity, underlying pulmonary 
diseases, neuromoscular disorders and metabolic 
syndrome were associated with the development 
of hypoxaemia. These variables were entered in a 
multivariate regression model with hypoxaemia 
as the dependent variable. As seen in Table 4, the 
metabolic syndrome and underlying pulmonary 
co-morbidities were independently associated 
with the development of hypoxaemia during 
the course of infection with influenza A (H1N1) 
pdm09 virus in Qazvin province, Iran.
n DISCUSSION
Since a long time ago, there have been numer-
ous evidences regarding the role of obesity in the 
occurrence and severity of infectious diseases. 
By changing of lifestyle and nutritional habits, 
the overweight and obesity turned into one of 
the major problems of human communities [16]. 
Obesity has been considered as one of the most 
common causes of mortality and morbidity in de-
veloped countries and is turning out to become 
Table 1 - Demographic characteristics of patients with 
confirmed influenza A (H1N1) pdm09 infection.
%No./Total No.Characteristics
Age group
23.613/5512-20 yrs
61.834/5521-50 yrs
14.58/55>51 yrs
Gender
43.624/55Female gender
Occupation
20.411/54Student
3.72/54Teacher
29.616/54Housewife
13.02/54Health Care worker
5.63/54Office employer
9.35/54Military employer
11.16/54Shop keeper
3.72/54Driver
9.35/54Worker
3.72/54Unemployed
Table 2 - Clinical characteristics and laboratory test results of patients with confirmed influenza A (H1N1) pdm09 
infection, based on gender.
P-ValueMaleFemale
0.01723.8 ± 3.826.8 ± 5.1BMI (kg/m2)
0.000173.5 ± 9.3154.2 ± 8.2Height (cm)
0.01572.3 ± 14.563.3 ± 11.2Weight (kg)
0.23189.4 ± 9.992.7 ± 10.4Waist circumference (cm)
0.245124.5 ± 15.5119.6 ± 15.3Systolic Blood Pressure (mmHg)
0.10275.8 ± 10.770.8 ± 11.4Diastolic Blood Pressure (mmHg)
0.848102.2 ± 26.4100.5 ± 37.5Fasting Blood Sugar (mg/dL)
0.909158.5 ± 84.8160.0 ± 74.1Serum triglyceride (mg/dL)
0.54235.8 ± 7.937.3 ± 10.0Serum HDL cholesterol (mg/dL)
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a principal health problem in developing coun-
tries [17]. However, it has to be noticed that this 
increase in the number of cases of overweight and 
obese individuals shows an uneven distribution 
throughout the society and there is a considerable 
variation based on gender, race, and age groups 
in different countries. In a study carried out in 
the USA, it was shown that while an increase in 
obesity of men and children was obvious within 
a 10 year period no such increase among women 
established [18]. In contrast, the obesity in wom-
en in Iran is turning into one of the major health 
problems and the rate of obesity among Irani-
an urban women has become even greater than 
American women [19]. One of the aspects of this 
global epidemic is the reciprocal effect of obesi-
ty and inflammatory responses. Contrary to our 
previous belief by which the adipose tissue was 
known as a place to store energy, currently it has 
become evident that the adipose tissue is integral-
ly involved in coordinating a variety of biological 
processes including energy metabolism, neuroen-
docrine function, and immune function [20]. Sim-
ilar to malnutrition, that clearly causes the poor 
function of the immune system, the obesity is 
also accompanied with functional disorder of the 
body defense mechanisms and probably increase 
in mass of adipose tissue induce the chronic ag-
gravation of the pro-inflammatory responses of 
Th-1 type [21, 22]. 
Table 3 - The relationship between demographic characteristics, underlying diseases and laboratory test results 
with hypoxaemia in confirmed cases of influenza A (H1N1) pdm09. Data are presented as mean ± SD for quantita-
tive variables or numbers (percentage) for dichotomous variables.
P ValueHypoxaemic patients 
(n=24)
Non hypoxaemic patients 
(n=31)
0.34334.2 ± 15.930.2 ± 14.6Age (year)
0.40212 (50.0)12 (38.7)Gender (female)
0.01129.4 ± 4.024.2 ± 5.0BMI (female)
0.01425.9 ± 3.922.6 ± 3.2BMI (male)
0.386166.3 ± 14.6166.4 ± 11.7Height (cm)
0.01773.4 ± 12.764.5 ± 13.5Weight (kg)
0.00595.1 ± 7.687.5 ± 10.7Waist circumference (cm)
0.1246 (25.0)3 (9.7)Diabetes Mellitus
0.0226 (25)1 (3.2)Neuromoscular disorders
0.4091 (4.2)3 (9.7)Cardiac co-morbidity
0.00015 (62.5)2 (6.5)Pulmonary co-morbidity
0.00218 (75.0)10 (32.3)Overweight & obesity
0.00021 (87.5)5 (16.1)Metabolic syndrome
0.122126.0 ± 14.5119.5 ± 15.8Systolic blood pressure (mmHg)
0.20275.8 ± 11.271.9 ± 11.0Diastolic blood pressure (mmHg)
0.380105.7 ± 31.798.1 ± 31.3Fasting blood sugar (mg/dl)
0.069181.6 ± 86.2142.0 ± 70.8Serum triglyceride (mg/dl)
0.14934.5 ± 8.438.0 ± 9.0Serum HDL cholesterol (mg/dl)
Table 4 - Results of multivariate logistic regression analysis of factors influencing the development of hypoxae-
mia in influenza A (H1N1) pdm09 throughout the province of Qazvin, Iran.
P valueOR (CI 95%)
0.66391.77 (0.14-22.92)Neuromuscular disorders
0.02339.54 (1.36-66.88)Pulmonary co-morbidity
0.019518.66 (1.60-217.47)Metabolic syndrome
0.92400.89 (0.08-10.43)Overweight & obesity
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The fact that the insulin resistance plays a positive 
role in improving the function of the immune sys-
tem during acute infections, could have been ac-
counted as an evolutionary advantage in the past, 
and perhaps at the present time in communities 
with high level malnutrition, as in an animal 
model the higher resistance to cerebral malaria in 
obese mice has been shown [23, 24]. 
However, in animal models, the chronic obesi-
ty has led to delayed proinflammatory cytokine 
expression, diminished natural killer cell cyto-
toxicity, and increased mortality in influenza in-
fection [25]. Moreover, obesity causes poor innate 
immune response through disrupting the macro-
phage function in producing an efficient response 
against bacteria by provoking an appropriate in-
flammatory reaction [26]. 
Diet-induced obesity impairs the innate immune 
response to bacterial infection via a mechanism 
that damages the ability of their macrophages 
to respond effectively to bacteria and mount an 
adequate inflammatory response. Although the 
course of respiratory diseases in obese individu-
als is generally more severe and with longer time 
for recovery [27]. However, it is likely that giving 
more attention to other risk factors associated 
with obesity, in particular among aged people, 
caused the obesity not to be routinely consid-
ered among the independent risk factors for oc-
currence of complications in infection with the 
other strains of influenza virus [28]. At present, 
the role of obesity as a risk factor for incidence 
of severe complications and mortality has become 
more evident, according to several studies asso-
ciated with influenza A (H1N1) pdm09 in which 
the higher incidence of severe complications oc-
curred in over weighted young individuals with-
out co-morbid risk factors [11, 29]. 
It has to be noted that in previous animal models 
with acute influenza infection, a decrease in ex-
pression of proinflammatory cytokine and natu-
ral killer cells and also an increase in mortality of 
influenza in obese mice has been described. More-
over, high level of leptin in obese mice is reported 
to have caused leptin resistance, whereas in an-
imal model of influenza infection, compared to 
underweight mice, not only there was no increase 
in the level of leptin but a decrease in concentra-
tion of leptin was obvious [25]. In the human cas-
es of influenza A (H1N1) pdm09, an increase in 
concentration of Th-1 and Th-17 cytokines during 
the acute phase of disease in severely ill patients 
is reported and in particular high levels of IL-6 
and IL-8 cytokines have been associated with 
more severe disease [30]. 
Although the real cause of more severe course and 
increased mortality of influenza in obese persons 
is not known, but it is clear that the level of leptin, 
TNF-α, IL-6, and IL-1β in people with more adi-
pose mass is chronically higher than normal indi-
viduals, whereas the concentrations of adiponec-
tin and mannan binding lectin (MBL) are report-
ed to be less than normal persons [7, 31]. Also, it 
has to be noted that these metabolic changes are 
mostly due to abdominal fat in particular those of 
omentum and mesenteric areas [32]. Thus, BMI is 
only an approximate reflection of adipose tissue 
mass, and due to the presence of different obesi-
ty phenotypes, there is no linear association be-
tween BMI and the amount of abdominal fat [8]. 
This issue that all obese people are not necessarily 
affected by metabolic syndrome has been suggest-
ed long time ago, and even at present, there are 
many researchers that believe in the existence of 
fat fit people [33, 34]. This has led to define a new 
category as metabolically healthy obese (MHO) 
people, in whom the risk of metabolic complica-
tions is at a level between those occurring among 
people with normal weight and those seen in in-
sulin resistant obese people [35, 36]. 
In a study carried out on post-menopausal obese 
women aged 50-71, it was demonstrated that the 
level of abdominal fat in obese people without 
metabolic syndrome was 49% less than obese 
people with metabolic syndrome [37]. In another 
study, a lower level of both abdominal fat and car-
diac intracellular lipid is reported in youngsters 
without resistance to insulin [38]. Hence, many 
researchers believe that the obese people with 
less resistance to insulin have less abdominal fat 
and occasionally up to 43% of obese people were 
reported to have resistance to insulin, metaboli-
cally [39]. Similarly, there are people at risk of 
metabolic complications despite having a normal 
BMI and defined as metabolically obese normal 
weight (MONW) individuals in whom resistance 
to insulin as well as abdominal and visceral obe-
sity are generally evident [40]. 
In our study, a significant correlation between hy-
poxaemia and BMI was discovered when using 
univariate analysis. However, when multivariate 
analysis was employed, our data showed it is the 
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metabolic syndrome, which is the risk factor for 
severity of disease and not the BMI. In the first 
100 deaths with diagnosis of influenza A (H1N1) 
pdm09 in Mexico city the prevalence of metabolic 
syndrome was 39,5 percent compared to 14.5 per-
cent in the general population [41]. In the men-
tioned study the prevalence for obesity for the two 
groups were 25.7 and 24.2 percent, respectively. 
In a case control study performed in 177 hospi-
tals in Brazil, obesity was an independent risk 
factor of mortality in influenza A (H1N1) pdm09 
[42]. In a study carried in Qatar, obesity was not 
associated with poor outcome in critically ill pa-
tients admitted with influenza A (H1N1) pdm09 
in intensive care units [43]. In 74 confirmed cases 
of influenza A (H1N1) pdm09 in Turkey a higher 
BMI was an independent risk factor for mortality 
[44]. In our study metabolic syndrome and BMI 
were strongly associated. It has to be noticed, it is 
likely that the findings associated with correlation 
between outcome measures and BMI, in influen-
za A (H1N1) pdm09 obtained in previous studies, 
are mostly related to metabolic syndrome rather 
than BMI, as these variables are strongly associat-
ed with each other.
n CONCLUSION
The findings of the present study once again con-
firm the role of the metabolic syndrome in the 
course of infectious diseases. Considering the 
data observed in our study, it is of vital impor-
tance to pay more attention to signs and symp-
toms of influenza in patients with metabolic 
syndrome and the process of decision making 
on hospitalization and initiation of antiviral ther-
apy for such patients to be carried out with less 
scruple. In addition, the interference of metabolic 
syndrome in statistical analyses associated with 
risk factors such as intubation, hospitalization in 
ICUs, and mortality may produce similar results 
when performed on a larger study population. 
The lower number of cases in the province of Qa-
zvin was our most important limitation in gen-
eralizing the findings of the present study. Due 
to the low number of hospitalized cases in ICUs 
and also low mortality rate, no significant differ-
ence between the risk factors and these variables 
was observed, statistically. Considering a total of 
only 9 hospitalized patients in ICUs and 2 cases 
of death, studying the role of the metabolic syn-
drome in severity of influenza A (H1N1) pdm09 
infection clearly needs further investigations on 
larger study population. Inclusion of metabolic 
syndrome in statistical analyses associated with 
risk factors such as intubation, admission to ICUs, 
and mortality in future studies with larger popu-
lation size may provide new insights into the pos-
sible correlation between metabolic syndrome, 
obesity, and severity of influenza. 
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